Sovereign s Capital Management LLC Increases Stake in Molina Healthcare, Inc $MOH

Sovereign s Capital Management LLC increased its position in shares of Molina Healthcare, Inc (NYSE:MOH) by 6.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 43,283 shares of the company’s stock after purchasing an additional 2,631 shares during the quarter. Molina Healthcare accounts for about 4.6% of Sovereign s Capital Management LLC’s investment portfolio, making the stock its 2nd largest holding. Sovereign s Capital Management LLC owned about 0.08% of Molina Healthcare worth $7,511,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Persistent Asset Partners Ltd bought a new position in Molina Healthcare during the fourth quarter worth $8,900,000. Militia Capital Partners LP bought a new position in Molina Healthcare during the fourth quarter worth $1,909,000. Cynosure Group LLC lifted its stake in Molina Healthcare by 188.8% in the fourth quarter. Cynosure Group LLC now owns 3,211 shares of the company’s stock valued at $557,000 after buying an additional 2,099 shares during the last quarter. Alberta Investment Management Corp bought a new stake in Molina Healthcare in the fourth quarter valued at $1,562,000. Finally, Yost Capital Management LP bought a new stake in Molina Healthcare in the fourth quarter valued at $5,206,000. 98.50% of the stock is currently owned by institutional investors.

Molina Healthcare Price Performance

Shares of NYSE MOH opened at $200.08 on Wednesday. The firm’s 50-day simple moving average is $177.24 and its 200 day simple moving average is $165.38. The stock has a market cap of $10.42 billion, a P/E ratio of 59.19 and a beta of 0.80. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $311.52. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The firm had revenue of $10.80 billion for the quarter, compared to analysts’ expectations of $10.91 billion. During the same period in the previous year, the business earned $6.08 earnings per share. Molina Healthcare’s revenue for the quarter was down 3.1% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities analysts expect that Molina Healthcare, Inc will post 5.23 EPS for the current year.

Insider Activity

In other Molina Healthcare news, insider Jeff D. Barlow sold 17,811 shares of the business’s stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the sale, the insider directly owned 67,175 shares in the company, valued at approximately $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Maurice Hebert sold 600 shares of the business’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the sale, the chief accounting officer owned 12,815 shares in the company, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 1.44% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on MOH shares. Bank of America upgraded Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price on the stock in a research note on Wednesday, April 29th. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $129.00 target price on shares of Molina Healthcare in a research note on Friday, April 24th. Mizuho set a $215.00 target price on Molina Healthcare in a research note on Monday, June 8th. Morgan Stanley lifted their price objective on shares of Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Finally, Zacks Research upgraded shares of Molina Healthcare from a “strong sell” rating to a “hold” rating in a research note on Monday, April 20th. Three equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $182.73.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.